Thursday, 22 October 2015

Senior Drug Safety Specialist-Dr. Reddy's Laboratories Ltd.




Dr. Reddys Laboratories Ltd.



 Job Description:

Quality check and review of individual case safety reports (ICSRs) based on accepted industry and regulatory guidelines.
Write various safety reports for global regulatory submissions including Annual Reports (IND and other), Periodic Safety Update Reports, Periodic Adverse Drug Experience Reports, Bridging reports
Assist pharmacovigilance teams in writing narratives for the adverse drug reactions and adverse events.
Review of literature search output or other data sources to identify reportable adverse drug reactions based on accepted industry and regulatory guidelines
Implement and promote use of consistent, efficient and quality processes to meet timelines and deliverables according to requirements and standard operating procedures, and assume accountability for the deliverables
Overview compliance of ICSR with governing regulatory requirements

Skills
Masters degree in Pharmacy or Life sciences with at least 3-4 years of experience in the pharmacovigilance.
Prior experience of ICSR processing in pharmacovigilance/drug safety field.
Experience of aggregate report writing specially PBRER.
Familiarity with the global reporting and regulatory requirements for pharmaceutical companies as mandated by drug safety authorities.
Strong written and verbal language skills
Ability to analyze and synthesize medical information.
Eye for quality, detail orientation for various pharmacovigilance processes.

Recruiter Name:Venkat Vishwanath

Senior Drug Safety Associate - Aggregate Reporting-Synowledge PV Services India Pvt Ltd



Synowledge PV Services India Pvt Ltd Careers
JOB TITLE: Senior Drug Safety Associate - Aggregate Reporting

LOCATION: Mysore, India.

YEARS OF EXPERIENCE: Minimum 2 years of experience in AR.

EDUCATION: Bachelors degree in Pharma/equivalent in a related discipline.

ESSENTIAL DUTIES AND RESPONSIBILITIES: 

As Lead Author: 
 
Lead/Co Lead cross functional teams contributing to periodic safety reports in accordance with Global Pharmacovigilance and Risk Management (GPRM) business rules, standard operating procedures (SOPs), and global regulatory requirements.
Support roles involved in creation of Aggregate Safety Reports (ASRs) (i.e. PSURs, PADER, DSURs, PBRERs, Addendum to Clinical Overviews, Addendum to PSURs, Summary Bridging Reports and RMP Updates).
Review aggregate safety data from the database and generate line listings (LL) and summary tabulations (ST) and include the LL & ST in the appropriate template.
Compile the safety data into the relevant sections of periodic reports such as PBRER, PADER, and DSUR according to the client.
Reviews and identify the literature that is selected for inclusion in the regulatory document that may lead to the signal deduction.
Create all documents in accordance to all applicable SOPs, and convention of the client.
Plan, organize, and manage daily work to meet service level timelines and deliverables.
Work with the Aggregate Reporting lead to escalate issues or tasks outside the normal scope of work.
Provide word and PDF versions of the final signed documents to the client.
Participate in internal and external audits and inspections by clients and health authorities.

APPLY ONLINE

Pharmacist (fresher most Welcome)-3,50,000 - 8,00,000 P.A.

Bengaluru/Bangalore , Mumbai , Pune , Hyderabad / Secunderabad , Chennai , Delhi/NCR(National Capital Region)
 
We have urgently required the Fresher candidates and Fresher Candidate can apply directly also to send their resume and one passport size photograph to our company email address - apply@khaitangroup.com 
 
Wish you and your family members a happy and prosperous festive season. Hope it will bring more happiness, peace and success into our life.

Idea to Market: The Drug Approval Process-It's a journey


Drug development can generally be divided into phases. The first is the preclinical phase, which usually takes 3 to 4 years to complete. If successful, this phase is followed by an application to the FDA as an investigational new drug (IND). After an IND is approved, the next steps are clinical phases 1, 2, and 3, which require approximately 1, 2, and 3 years, respectively, for completion ( Table ). Importantly, throughout this process the FDA and investigators leading the trials communicate with each other so that such issues as safety are monitored. The manufacturer then files a new drug application (NDA) with the FDA for approval. This application can either be approved or rejected, or the FDA might request further study before making a decision. Following acceptance, the FDA can also request that the manufacturer conduct additional postmarketing studies. Overall, this entire process, on average, takes between 8 to 12 years. Figure 1 summarizes the drug approval process.

Read more

Saturday, 17 October 2015

Biomarkers in Preclinical Drug Development: Current and Future States.



Biomarkers are commonly used in clinical trials to identify organ injury before it becomes clinically evident. While they add value in early discovery work and in human trials to identify major safety issues, their potential has not yet been fully reached in preclinical development in animals. This paper explores the current state of biomarker use in preclinical development and examines possible steps for future use. Current State One Piece of the Puzzle It’s important to note that biomarkers must be used in conjunction with other traditional clinical and pathology endpoints. When used with other data, they can be used to identify premonitory signals signifi cantly earlier than when utilizing traditional tests alone. But there may be instances in which biomarker results can confound data interpretation. Due to the sensitivity of many biomarker assays, a biomarker may show evidence of a certain toxicity in the absence of correlative fi ndings among other, more traditional study endpoints. In these cases the biomarker may be identifying a submicroscopic eff ect that cannot be detected through traditional means. Since biomarker use in preclinical studies is not a regulatory requirement, some scientists are hesitant to use biomarkers because they are concerned about explaining these results. Therefore, it’s important to discuss the benefi ts and potential drawbacks of using biomarkers during the planning stages of a toxicity study. The more that is understood about the mechanisms involved in the biomarker’s signaling pathways, the easier it is to explain its results. A pathologist should be consulted pre-study to determine how and when to use the biomarker most eff ectively. Understanding the timing of the pathologic processes involved is critical to yielding meaningful results. For example, it may be necessary to draw blood samples within hours or days of dosing to capture the positive signal instead of waiting until the end of the study when the signals may no longer persist. Quality over Quantity Ideal biomarkers must function both analytically and from a pathological perspective, so while analytical teams are continually discovering new biomarker targets, there must be collaboration with pathologists to ensure these markers will be useful in practice. What are the characteristics of a good biomarker? A good biomarker must be present in body tissue and/or fl uids, easy to detect in aff ordable assays, and “its appearance must be associated as specifi cally as possible with damage of a particular tissue, preferably in a quantifi able manner.” 1 What are the characteristics of a validated biomarker? While it’s fairly straightforward what makes a good biomarker, characteristics of a validated biomarker are still up for debate. The Predictive Safety Test Consortium (PSTC) was created by scientists in academia and industry with the goal of qualifying new biomarkers “for the detection and monitoring of drug-induced toxicity in preclinical and clinical studies.”2 • In 2008, Kidney injury molecule-1 (Kim-1, in rodents), along with six other markers, was approved by the FDA as an acceptable biomarker “for the detection of acute drug-induced nephrotoxicity in rats and can be included along with traditional clinical chemistry markers and histopathology in toxicology studies.”3,4 • In 2010, the FDA published guidance on the Qualifi cation Process for Drug Development Tools, which stated that “qualifi cation is a conclusion that within the stated COU [context of use], the [drug development tool] can be relied on to have a specifi c interpretation and application in drug development and regulatory review.”5 Qualifi cation through the FDA is voluntary, and the COU can be expanded incrementally over time with appropriate data. • In the last several years, troponins have been established as a reliable biomarker for cardiovascular injury.6 In 2012, they were concluded by the FDA to be qualifi ed biomarkers for use in rats and dogs, in certain preclinical circumstances.7 While organizations like the PSTC continue to make strides in developing tests for biomarkers for preclinical use, minimum threshold criteria for an acceptable validation of a preclinical biomarker have not been published (the way they have been for clinical biomarkers), so there is still a spectrum of what is considered a validated or qualifi ed biomarker. Many preclinical labs involved in biomarker work adopt similar validation practices, which usually include inter/intra-assay precision and accuracy, dynamic range, upper and lower limits of quantitation, dilution linearity, spike-and-recovery, parallelism, and stability, but agencies have yet to create standardized guidance for all labs to follow. Lack of Oversight The manufacture of biomarker kits used in preclinical studies is not currently regulated, so one cannot assume that every kit on the market is functional. Individual labs must do the due diligence for each kit to ensure analytical performance, as well as performance from a biological perspective (e.g., using serum samples from animals with a known pathology to verify kit functionality). This can be a large investment upfront, but establishing a reliable kit supplier and using preclinical biomarkers to detect injury early can save considerable time and money once a drug program is underway. Individual methods must also be taken into account: two diff erent kits may use completely diff erent methods for the same biomarker, so it’s advisable to maintain consistency of methods and manufacturer throughout a program to ensure an apples-to-apples comparison between results from diff erent studies. This may not always be possible between species as species-specifi c reagents are not available for all biomarkers. Future State In order for preclinical studies to truly reap the full range of benefi ts that biomarkers can off er, we hope to see a few changes over the next several years. Standardization is Crucial The industry needs more guidance from regulatory agencies on the minimum requirements for validation, so that each lab can universally adhere to one set of standards. This will help to remove the subjective nature of what a “good” biomarker is and will result in a consistent set of standards used across the industry. The Biomarker Qualifi cation Review Team (BQRT), comprised of reviewers from CDER and other FDA branches, also acknowledges that “a standardized format for submitting preclinical and clinical data is needed for an effi cient and accurate review.”8 Establishing a Trustworthy Set Biomarker development needs collaboration between pathologists and analytical groups. Both types of specialists are critical to developing biomarkers that are useful in preclinical studies. Once more standards for validation and data submission are established by regulatory agencies, teams can work together to streamline the discovery of preclinical biomarkers and submission for review. As more biomarker data is collected and made accessible to the community, more time can be saved in choosing the appropriate marker for a study, and in understanding sensitivity and interpreting results. Page 2 of 3 Adam A. (2014) Biomarkers in Preclinical Drug Development.
Read more..

Friday, 16 October 2015

Record Management Clinical Research-Kelly Services India Pvt. Ltd.-Bengaluru/Bangalore

Kelly Services India Pvt. Ltd. Careers
2,00,000 - 4,00,000 P.A

Job Description

s
    Greetings from kelly services!

    We have an immediate openings for Clinical research Record management. Interested candidates can walkin on 19th October,2015.

    Experience : 0.6months to 4 years
    Venue : Sriram Samanthu Chambers, # 3287, 12th Main Indiranagar, Bangalore| India 560038
    Near HDFC bank, Salary:INR 2,00,000 - 4,00,000 P.A
    Recruiter Name:Sarada

Thursday, 15 October 2015

How Companies Can Make the Most of Their Early Drug Development Stage

Background




















Companies large and small face enormous risks during the crucial early drug development stages. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), major pharmaceutical and biotechnology companies spent $10.5 billion or 22% of total annual R&D costs on non-clinical research in 2011 — more than the total amount spent on Phase I and II activity combined.i While the failure rate tends to diff er for small molecules and biologics, the majority of development eff orts fail, with the rate generally falling between 60 and 90%. With the new technologies and services available to Sponsors, the traditional path to drug development is no longer the best solution. With the right planning and tools, the studies conducted in the preclinical and early clinical stages can lay a foundation that will reduce risk and maximize the investment in future stages.

Focus on De-Risking a Molecule: The Rise of Translational Medicine

Facing rising R&D costs and increasing pressure to appease investors, companies must discover early on if a potential drug is too risky to pursue. There are many risks in early drug development, which can be grouped into three main categories: safety, efficacy, and time to market. To mitigate the risk in the latter category, companies must move with insightful speed — performing the right studies to obtain the best data — to stay ahead of competitors. The knowledge that a potential drug carries too much risk can save millions, and it also builds trust with stakeholders who see that there are sound decision-making processes in place, and that resources are being carefully allocated. 

Wednesday, 14 October 2015

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Nanoparticle flow, margination and adhesive properties in blood vessels are dependent on particle size and geometry.
Biological barriers to drug transport prevent successful accumulation of nanotherapeutics specifically at diseased sites, limiting efficacious responses in disease processes ranging from cancer to inflammation. Although substantial research efforts have aimed to incorporate multiple functionalities and moieties within the overall nanoparticle design, many of these strategies fail to adequately address these barriers. Obstacles, such as nonspecific distribution and inadequate accumulation of therapeutics, remain formidable challenges to drug developers. A reimagining of conventional nanoparticles is needed to successfully negotiate these impediments to drug delivery. Site-specific delivery of therapeutics will remain a distant reality unless nanocarrier design takes into account the majority, if not all, of the biological barriers that a particle encounters upon intravenous administration. By successively addressing each of these barriers, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
Read More

Tuesday, 13 October 2015

Openings for Freshers- Pharmacovigilance-Bengaluru/Bangalore-2,00,000 P.A

Quintiles Careers

Job Description

 
Looking for freshers who has completed their graduation B.Pharma/M.Pharma/ BDS/ M.Sc/B.Tech.

RESPONSIBILITIES
Provide intake and tracking of initial safety and clinical event validation and adjudication (CEVA) data. Transfer incoming
safety/CEVA data to project team. Identify any problems with incoming faxes and bring them to the attention of the senior
team member.
Distribute safety data to marketing authorization holders, customers, regulators and investigators.
Specific project responsibilities include set-up and/or maintenance of safety/CEVA files for reported events; archiving of
files when closed; coordination of transfer of archived material to company/customer archive storage facilities;
preparation and assistance in setting-up and updating project files; maintenance of personal safety files for mail merges
and regulatory documents; where required, data entry of events into tracking database and assistance of transfer of
events to customers.
Provide administrative support for the department by coordinating team/department/customer meetings, coordinating
stationery orders, dispatching data via courier services, reserving meeting rooms and IT equipment; and providing
secretarial support as required.
Generate and distribute alert letters.
Identify and record quality problems and bring them to the attention of a senior team member.
Provide training/mentoring new/less experienced staff.
Assist project lead and CEVA management with specific aspects of CEVA processes.
Set up and maintain Serious Adverse Event (SAE) files for reported events; organize and send files for archive when
events are closed.
Coordinate, schedule and submit reports to regulatory authorities in accordance with deadlines.
Coordinate distribution of safety letters to study investigators and Clinical Research Associates.
Assist in processing incoming and outgoing Adverse Event (AE) reports by collecting and tracking incoming AE reports
sent via fax, email, eCRF, etc; determining initial/update status of incoming events; tracking timelines for completion of
AE processing; performing data entry into safety database; routing report information to appropriate PhV project
personnel in the workflow for continued processing; performing quality control activities as directed by project lead or
manager; generating established safety data reports; submitting AE reports to client and other project team members
identified by project lead; obtaining confirmation of report receipt and track submission; and assuming workflow
responsibilities for local and global projects.
Perform records management tasks such as creating and tracking case folders for AE reports; filing, retrieving and
delivering case folders; assisting in maintenance of document control room and relevant applications/systems as directed
by manager; archiving case folders and project files; assisting in creation of PhV records management processes and
procedures; providing key input to management on acquisition and/or upgrade of records management
application/systems; and serving as liaison between Pharmacovigilance department and records management
department.
Assist with system support tasks such as utilizing design specifications, AE form, and protocol, creating projectspecific
entry specifications and annotated AE forms for safety database with direction from project lead and/or manager;
creating project tracking spreadsheets and associated tracking entry specifications; assisting in database validation
through performance of user testing; performing ad hoc database searches for project team leads; assisting project lead
in assessing database setup needs; and assisting with assuring systems issues are reported and resolved.
Perform additional project-related and administrative tasks such as handling investigator mailings including creation of
labels using investigator list, copying of documents, envelope stuffing, and tracking and filing of submitted materials;
creating and maintain project files; working with project lead to develop project instructions; performing reconciliation
between the safety and clinical databases; distributing AE listings to client and/or project team members; performing
project start-up tasks; providing project metrics to management; and assisting with data entry, workflow and deadline
quality measurements.
Participate in continuous improvement of all departmental processes and procedures.
All responsibilities are essential job functions unless noted as nonessential (N).
REQUIRED KNOWLEDGE, SKILLS AND ABILITIES
Basic knowledge of ICH and GCP
Basic knowledge of medical terminology if processing
Good understanding of Core Operating Procedures (COPs)
Word processing and data entry skills
Strong organizational skills and time management skills
Flexibility and excellent verbal and written communication skills
Ability to deal successfully with many internal clients competing for attention, services and resources
Good attention to detail and accuracy
Ability to establish and maintain effective working relationships with co-workers, managers and colleagues.
Highly motivated and organised with a flexible attitude
Ability to follow instructions/guidelines, utilize initiative and work independently
Ability to establish and maintain effective working relationships with coworkers, managers and clients


APPLY ONLINE

Quintiles Hiring Clinical Research Professionals - 17-oct-15 Hyderabad

Quintiles Careers

Job Description

Walk in Interview - Quintiles on 17-Oct-15 for ClinicalResearch Professionals in Hyderabad. Key Skills:- CRC, CPC, CRA, Research, Clinical Research, Scientists, Medical Writing, CDM, PV.


Experience 3-8 years.
Hyderabad Interview Venue Details:-

Aditya Park- A Sarovar Portico Hotel
Aditya Trade centre | Ameerpet | Hyderabad -38
Registration Time:- 8am


Position 1: Clinical Process Specialist/Analyst

PURPOSE
Apply clinical research expertise to provide project related assistance across complex and multiple  project(s), sites and project teams. Lead teams functionally, where assigned, including awareness of scope of work, budget, and resources. Ensure all work is conducted in accordance with SOPs, policies and practices, good clinical practices and applicable regulatory requirements and meets quality and timeline metrics.


RESPONSIBILITIES

Perform complex processes and tasks that eventually result in high quality deliverables that are completed according to service level agreements (SLAs) and within project timelines                                                                                                                                                                                   
Establish and maintain effective project/ site communications                                                                           
Create and maintain relevant project documents// trackers                                                                                                                                                                                                                                    
Ensure accurate completion and maintenance of internal systems, databases, tracking tools, timelines and project plans with project specific information                                                                                                                                  
Review, evaluate and recommend modifications to designated processes
Oversee and participate in document management (creation, review, maintenance, storage, as applicable)
Participate in (study) team meetings and implement action items
Collaborate with the project lead/team members in creation/review of study documents
Act as point of contact for assigned deliverables for specific customers or projects
Evaluate the quality and integrity of study site practices related to the proper conduct of the protocol and adherence to applicable regulations.
Escalate quality issues to relevant stakeholders and/or line manager


Position 2: Sr Clinical Process Specialist

PURPOSE

Apply clinical research expertise to provide project related assistance across complex and multiple project(s), sites and project teams. Lead teams functionally, where assigned, including awareness of scope of work, budget, and resources. Ensure all work is conducted in accordance with SOPs, policies and practices, good clinical practices and applicable regulatory requirements and meets quality and timeline metrics. Mentor/ coach Clinical Process Associate/Specialist colleagues.


RESPONSIBILITIES

Perform complex processes and tasks that eventually result in high quality deliverables that are completed according to service level agreements (SLAs) and within project timelines                                                                                                                                                                                   
Establish and maintain effective project/ site communications                                                                           
Create and maintain relevant project documents/ trackers                                                                                                                                                                                                                                     
Ensure accurate completion and maintenance of internal systems, databases, tracking tools, timelines and project plans with project specific information                                                                                                                                  
Review, evaluate and recommend modifications to designated processes
Oversee and participate in document management (creation, review, maintenance, storage, as applicable)
Participate in (study) team meetings and implement action items
Collaborate with the project lead/team members in creation/review of study documents including Quality manuals
Act as point of contact for assigned deliverables for specific customers or projects
Evaluate the quality and integrity of study site practices related to the proper conduct of the protocol and adherence to applicable regulations.
Escalate quality issues to relevant stakeholders and/or line manager.
Coach junior clinical process associate/specialists


Interested Candidates can Walk In to the above mentioned address or forward the CV to Sindoora.kn@quintiles.com.
 

Clinical Research Coordinator TECH OBSERVER

 
 1,25,000 - 2,00,000 P.A

Job Description

 
Recruitment,coordination & follow up of trial subjects, covering informed consent, adhering to safety and compliance issues;sample collection & shipment;Administer study drug;Coordination & management of Clinical Trial; 
 

Monday, 12 October 2015

Regulatory Affairs-A career with global exposure

Regulatory Affairs Professionals act as a link between companies and regulatory authorities, ensuring that products are researched, manufactured and distributed in compliance with appropriate legislation.

Key duties of the job include:
  • studying scientific and legal documents
  • gathering, evaluating, organising, managing and collating information in a variety of formats
  • ensuring compliance with USFDA, MHRA regulations
  • maintaining familiarity with company product ranges
  • planning, undertaking and overseeing product trials and regulatory inspections
  • keeping up-to-date with changes in regulatory legislation and guidelines
  • analysing complicated information, including trial data
  • offering advice about company policies, practices and systems
  • obtaining marketing permission
  • outlining requirements for labelling, storage and packaging
  • using a variety of specialist computer applications
  • liaising and negotiating with regulatory authorities
  • providing advice about regulations to manufacturers/scientists
  • writing comprehensible, user-friendly, clear product information leaflets and labels
  • ensuring that quality standards are met and submissions meet strict deadlines
  • preparing documentation.

Qualifications and training required

The minimum necessary qualification is an appropriate subject (chemistry, physics, biochemistry, biotechnology, pharmacy, medicinal chemistry, biomedical science, life or applied science).
A relevant postgraduate qualification (PhD or research-based MSc) is also helpful, particularly for permanent positions. Post-doctoral research, practical research or laboratory work experience is also beneficial - regulatory affairs experience is particularly sought after. Certification in Regulatory Affairs [USFDA, MHRA, CDSCO, EU etc.] may be highly helpful to get jobs.

Key skills for Regulatory Affairs professionals

  • IT skills
  • Negotiation skills
  • Analytical skills
  • Time management skills
  • Problem solving skills
  • Presentation skills
  • Interpersonal skills
  • Communication skills
An understanding and appreciation of relevant legal, scientific and manufacturing areas is also necessary.

What is Clinical Research?

The National Institutes of Health defines “clinical research” as research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual.Clinical research includes:
  • Patient-oriented research – This type of research involves a particular person or group of people, or uses materials from humans. This research can include 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies
  • Epidemiological and behavioral studies – These types of studies examine the distribution of disease, the factors that affect health, and how people make health-related decisions.
  • Outcomes and health services research – These studies seek to identify the most effective and most efficient interventions, treatments, and services

Sunday, 11 October 2015

Drug Safety Associate-PAREXEL International (India) Pvt. Ltd.- Hyderabad / Secunderabad , India - Telangana - Hyderabad

PAREXEL International (India) Pvt. Ltd. 

Job Description

 
    The DrugSafetyAssociate will provide technical and process-related support to drugsafety management (clinical trial and post-marketed) and medical monitoring activities, regulatory information collection and organization, ensuring compliance with relevant regulations and Standard Operating Procedures (SOPs).
    For members of the Global Pharmacovigilance Information Office (GPIO):
    o Support collection and organization of global PV requirements
    o Data entry and maintenance of country specific requirements in PAREXEL PV repository
    o Receipt and triage of requests for updates to country requirements
    o Communicate country-specific regulatory updates to project teams as required
    o Maintain updated network list of Named Safety Contacts/LQPPV
    o Work directly with relevant stakeholders on standalone GPIO projects 

Regulatory Affairs Intern (london) - Only for 6 Months

Meyer Organics Pvt. Ltd. Careers

Job Description

 
    • Preparation, compilation & submission of Dossiers in CTD, ACTD as well as country specific format For African, Southeast Asian, and Latin America countries like. Kenya, Nigeria, Ghana, Philippines, Myanmar, Vietnam, Sri Lanka, Cambodia, Guyana, Guatemala, EL Salvador, Tanzania, Syria, Yemen etc. 
    • Responding to technical queries related to product registration.
    • Evaluation and preparation of post approval supplements to manage the regulatory product as applicable.
    • Coordinate and consult with other department for accurate and timely assembly of regulatory document for submissions.
    • Knowledge of New Product Development. 
    • Reviewing technical documents and checking of Artworks as per the countries guidelines.
    • Co-ordination with International Customers 
    • Technical data support to dossier preparation for UK.
    • Replying to product based queries on the basis of clinical studies asked by medical fraternity. 
    • Keeping up-to-date with changes in regulatory legislation and guidelines
  • APPLY ONLINE

Executive/ Assistant- Medical Writer InfocusRx Marketing & Communication Pvt. Ltd. - Hyderabad / Secunderabad

Job Description

 
Looking for a promising career and rewards?
Welcome to InfocusRx - Experts in medical content, design, and technology services. We are seeking candidates having professional qualifications like : Masters in Science, M-Pharma, MBBS, BDS, , BAMS, Pharma-D and relevant degree in Health Sciences to be a part of our in-house medical communication team.
Today, with its team synergy and expertise in research, content and design, the company focuses on providing content writing, business research, advisory, marketing, interactive and website design services for medical/healthcare verticals. Our clients include progressive start-ups, entrepreneurs, venture capitalists, Universities, mid-size and fortune 500 firms.

Job responsibilities
As medicalwriter you would be writing, editing and providing quality content for medical / health science training ware development.
You need to ensure accuracy and completeness of training document and format.
Should be able to perform other responsibilities as assigned.
To develop high-quality, publication-ready scientific documents (Monographs , Newsletters , Journal supplements , Booklets ,Leave-behinds ,Speaker kits ,Poster presentations, Continuous medical education (CME) ,Medical conference coverage)

APPLY ONLINE

Opening for Medical Writing- MBBS / MD at Indegene, Bangalore


Job Description
  • Develop content for various deliverables meeting quality requirements as per client satisfaction metrics, with active guidance from the manager
  • Responsible to develop content as per the timelines assigned
  • Responsible to follow the best practices in the department regarding - processes, communication (internal & external), project management, documentation and technical requirements like - language, grammar, stylization, content search, summarizing, data conflicts and referencing
  • Participate in assigned training programs and work on assignments as per requirement
  • Participate in client calls as per project requirements
  • Compliance to quality, confidentiality and security:
  • Adhere and follow quality systems, processes and policies
  • Comply to training and specifications
APPLY ONLINE

Job Profile of Pharmacovigilance Officer in Pharmacovigilance Project


• Responsible for processing Adverse Event cases on the Safety database.
• Perform the duplicate case search function in software.
• Review the source document to assure relevant information pertaining to the case is appropriately entered into the database fields.
• Responsible for processing Initial/Follow-up Spontaneous, Solicited, Clinical trial Serious/Non-serious Cases.
• Event Coding by MedDRA (Medical Dictionary for Drug Regulatory Activities).
• Assessment of events with product, also case validity.
• Used CDD (Company Drug Dictionary) and WHO Dictionary for drug coding.
• Completion of remaining case data entry, including narrative writing or Auto-narrative.
• Creation of follow-up letter for required cases.
• E2B Validation of the Case.
• Follow Up activities.
• E2B Linking reports and cross reference reports
• Routing of Spontaneous/Solicited/Clinical trial cases, Serious/Non-serious cases to the appropriate workflow state.
• Responsible for performing daily activities in accordance to applicable Standard Operating Procedures (SOPs), Conventions and Client policies.
• Quality auditing for cases